InflaRx NV (IFRX)
1.85
+0.03
(+1.65%)
USD |
NASDAQ |
Sep 29, 16:00
1.865
+0.02
(+0.81%)
After-Hours: 20:00
InflaRx Price : 1.85 for Sept. 29, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 29, 2026 | 1.83 | 1.89 | 1.80 | 1.85 | 268405.0 |
| Sep 28, 2026 | 1.88 | 1.954 | 1.80 | 1.82 | 426389.0 |
| Sep 25, 2026 | 1.94 | 2.04 | 1.87 | 1.89 | 399902.0 |
| Sep 24, 2026 | 1.97 | 2.02 | 1.89 | 1.93 | 510186.0 |
| Sep 23, 2026 | 2.08 | 2.09 | 1.96 | 1.96 | 564758.0 |
| Sep 22, 2026 | 2.12 | 2.19 | 2.041 | 2.08 | 571272.0 |
| Sep 21, 2026 | 2.11 | 2.19 | 2.065 | 2.12 | 345150.0 |
| Sep 18, 2026 | 2.07 | 2.11 | 2.025 | 2.09 | 292677.0 |
| Sep 17, 2026 | 2.05 | 2.10 | 1.98 | 2.06 | 657951.0 |
| Sep 16, 2026 | 2.02 | 2.069 | 1.99 | 2.04 | 821207.0 |
| Sep 15, 2026 | 2.12 | 2.165 | 1.99 | 2.02 | 579600.0 |
| Sep 14, 2026 | 2.15 | 2.20 | 2.10 | 2.12 | 545791.0 |
| Sep 11, 2026 | 2.07 | 2.11 | 2.04 | 2.09 | 334148.0 |
| Sep 10, 2026 | 2.05 | 2.07 | 1.98 | 2.05 | 613475.0 |
| Sep 09, 2026 | 2.15 | 2.15 | 2.05 | 2.09 | 759751.0 |
| Sep 08, 2026 | 2.19 | 2.26 | 2.11 | 2.17 | 408904.0 |
| Sep 04, 2026 | 2.21 | 2.377 | 2.16 | 2.22 | 393943.0 |
| Sep 03, 2026 | 2.30 | 2.370 | 2.18 | 2.23 | 666375.0 |
| Sep 02, 2026 | 2.16 | 2.34 | 2.133 | 2.29 | 572037.0 |
| Sep 01, 2026 | 2.12 | 2.27 | 2.09 | 2.16 | 475081.0 |
| Aug 31, 2026 | 2.21 | 2.23 | 2.09 | 2.13 | 447811.0 |
| Aug 28, 2026 | 2.28 | 2.37 | 2.21 | 2.23 | 610420.0 |
| Aug 27, 2026 | 2.40 | 2.435 | 2.245 | 2.27 | 1.406M |
| Aug 26, 2026 | 2.45 | 2.50 | 2.33 | 2.42 | 1.715M |
| Aug 25, 2026 | 2.06 | 2.46 | 2.01 | 2.46 | 3.894M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| MediGene AG | 0.10 |
| BioNTech SE | 98.57 |
| Immatics NV | 8.56 |
| Beam Therapeutics, Inc. | 24.52 |
| Kymera Therapeutics, Inc. | 110.51 |
Price Related Metrics
| PS Ratio | 2076.15 |
| Price to Book Value | 1.631 |
| Earnings Yield | -35.05% |
| Market Cap | 272.63M |